Loading...

Illumina, Inc.

0J8Z.L•LSE
Healthcare
Medical - Pharmaceuticals
£98.69
£-6.23(-5.94%)

Illumina, Inc. (0J8Z.L) Stock Overview

Explore Illumina, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 78.7/100

Key Financials

Market Cap16.9B
P/E Ratio11.96
EPS (TTM)$4.55
ROE0.53%
Fundamental Analysis

AI Price Forecasts

1 Week$83.80
1 Month$82.83
3 Months$112.07
1 Year Target$86.27

0J8Z.L Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Illumina, Inc. (0J8Z.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.29, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $86.27.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 11.96 and a market capitalization of 16.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;